COMMUNIQUÉS West-GlobeNewswire

Quantum-Si Demonstrates Detection of 19 Amino Acids in Proteus™ Development Program
08/10/2026
Company is working to deploy 19-amino-acid detection into a developmental sequencing kit and remains confident in demonstrating detection of all 20 amino acids by year-end 2026 BRANFORD, Conn., Oct. 08, 2026 (GLOBE [...]
NovaBridge Biosciences Announces Expanded Givastomig Safety and Efficacy Data to be Presented at the European Society for Medical Oncology 2026
08/10/2026
ROCKVILLE, Md., Oct. 08, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (NASDAQ: NBP) today announced that updated results from the Phase 1b combination study of givastomig, a Claudin 18.2 (CLDN18.2) x 4-1BB bispecific [...]
Agomab to Present STENOVA Open-Label Extension Data of Ontunisertib at UEG Week 2026 and Host Scientific Symposium on Fibro-Inflammation
08/10/2026
-- Open-Label Extension (OLE) Data of STENOVA Phase 2a study with ontunisertib in Fibrostenosing Crohn’s disease (FSCD) selected for oral presentation at UEG Week 2026 -- -- Results support initiation of global NOV-ERA [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
08/10/2026
ZUG, Switzerland, Oct. 08, 2026 (GLOBE NEWSWIRE) -- The attached notification relates to the vesting and settlement of RSUs previously granted to a member of the Company’s Executive Committee and Board of Directors. [...]
Rua Bioscience and PharmAla Biotech partner to supply medicinal MDMA in New Zealand
08/10/2026
TAIRĀWHITI, New Zealand and TORONTO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Rua Bioscience Limited (NZX: RUA) (“Rua”) and PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTCQB: MDXXF) (“PharmAla”) announce that Rua and PharmAla [...]
Sionna Therapeutics to Present Data at the 2026 North American Cystic Fibrosis Conference
08/10/2026
Previously disclosed post hoc PreciSION CF analyses of SION-719 support advancement of SION-451 + SION-2222 into the AscenSION CF Phase 2a proof-of-concept trial New preclinical data evaluating NBD1 stabilizers in [...]
Initiation of buy-back programme
08/10/2026
ANNOUNCEMENT NO. 320 8 October 2026 The Board of Directors of ChemoMetec A/S has decided to buy back own shares based on the authorisation granted at the Annual General Meeting on 8 October 2026. The authorisation is [...]
Clever Care Health Plan Achieves 4.5-Star Medicare Advantage Rating from CMS for Star Year 2027
08/10/2026
The rating arrives as Clever Care achieves significant growth and unveils its new benefits for 2027 HUNTINGTON BEACH, Calif., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Clever Care Health Plan , a culturally competent and [...]
Alignment Healthcare Earns 4 Stars or Higher for Six of Seven Eligible Medicare Advantage Contracts in CMS 2027 Star Ratings
08/10/2026
Three contracts achieve 4.5-Star ratings as Alignment remains focused on delivering high-quality, coordinated care for seniors ORANGE, Calif., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) [...]
New results across pediatric, adult and real-world insomnia settings highlight the expanding clinical evidence for daridorexant at Sleep Europe 2026
08/10/2026
Phase 2 results with daridorexant in pediatric insomnia disorder will be presented in a late-breaking "Impactful Clinical Trial" session. These are the first and only investigational data of a dual orexin receptor [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2026
08/10/2026
Nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2026
08/10/2026
Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité [...]
Clue Transforms Period Tracking Into a Gateway to Healthcare With Launch of Free ‘Get Care’ Initiative
08/10/2026
From tracking to action, Clue connects users directly with trusted care providers across contraception, conception, metabolic and mental health, perimenopause and at-home testing, supported by partners including Novo [...]
Zoumalan, MD FACS Inc. Introduces the Bella Lift, an Upper Face Rejuvenation That Treats the Brow and Eyelids Together
08/10/2026
As new ISAPS data shows eyelid surgery now leads for both women and men worldwide, Beverly Hills oculoplastic surgeon Dr. Christopher Zoumalan explains when the brow belongs in the plan Beverly Hills, CA, Oct. 08, 2026 [...]
Basel Medical Group Ltd (BMGL) Prices Registered Direct Offering
08/10/2026
Singapore, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) today entered into a placement agency agreement with Cathay Securities, Inc., as the placement agent (the “Placement [...]
Vascudyne’s Lab-Grown Vessel Passes the Two-Year Mark Supplying Blood to a Patient’s Heart as a Coronary Bypass
08/10/2026
Two-year clinical follow-up presented at EACTS 2026, highlighting the potential of Vascudyne’s bioengineered platform technology BARCELONA, Spain and ST. PAUL, Minn., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Vascudyne, Inc., a [...]
Procedure of the Annual General Meeting
08/10/2026
ANNOUNCEMENT NO. 319 8 October 2026 The Annual General Meeting of ChemoMetec A/S was held on 8 October 2026 at 17:30 at Nordsjællands KonferenceCenter. At the Annual General Meeting, the Board of Directors' report on [...]
Solu Therapeutics Initiates Dosing in Acute Myeloid Leukemia Cohort of the Ongoing Phase 1 Study of STX-0712
08/10/2026
BOSTON, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Solu Therapeutics, a biotechnology company pioneering novel therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced that [...]
Iantrek Expands Clinical Evidence for Bio-Interventional Ophthalmic Surgery Across Trabecular and Uveoscleral Outflow Pathways
08/10/2026
Six-month data on a new bio-reinforced canaloplasty procedure show 37% IOP reduction; new findings on bio-reinforced cyclodialysis to be presented at AAO 2026 WHITE PLAINS, N.Y., Oct. 08, 2026 (GLOBE NEWSWIRE) -- [...]

Pages